Pharmacy Compounding for Veterinary Medicine Market Forecast to Reach USD 2.35 Billion by 2030

The Pharmacy Compounding for Veterinary Medicine Market is a rapidly expanding sector, driven by the increasing demand for customized medications for a diverse range of animals. The market was estimated to be valued at approximately USD 1.44 billion in 2024 and is projected to reach USD 2.35 billion by 2030, with a compound annual growth rate (CAGR) of 8.45% during this period. Within this growth, anti-inflammatory agents represent a significant and high-opportunity segment.

Download the full report now to discover market trends, opportunities, and strategies for success.
https://evolvebi.com/report/pharmacy-compounding-for-veterinary-medicine-market-analysis/

The Role of Anti-inflammatory Agents
Anti-inflammatory agents, such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids, are crucial in veterinary medicine for managing pain and inflammation caused by conditions like osteoarthritis, injuries, and post-surgical recovery. While FDA-approved drugs exist, they are often not available in the necessary dosage forms, concentrations, or flavors for all animal species. This is where compounding plays a vital role. Pharmacists can create customized medications, such as flavored oral suspensions, transdermal gels, or smaller-dose capsules, that make it easier for pet owners to administer and ensure the animal receives the correct treatment. This enhanced patient compliance is a key driver for the demand for compounded anti-inflammatory agents.

Problems Faced
Despite the opportunities, the veterinary compounding market faces several challenges.
• Regulatory Scrutiny: Compounded medications are not subject to the same FDA approval process as commercially available drugs, raising concerns about their safety, efficacy, and potency. Studies have shown a wide variation in the effectiveness of compounded medications, with some products not containing the amount of active ingredient indicated on the label. This regulatory ambiguity and lack of consistent oversight can lead to serious adverse events.
• Cost and Sourcing: The lack of standardized formulas and the need for specific, high-quality ingredients can increase production costs. Additionally, the competition from large pharmaceutical companies with heavy R&D and marketing budgets poses a threat to smaller compounding pharmacies.
• Supply Chain Disruptions: Compounding relies on a consistent supply of Active Pharmaceutical Ingredients (APIs) and other raw materials, many of which are sourced internationally.

Download the full report now to discover market trends, opportunities, and strategies for success.
https://evolvebi.com/report/pharmacy-compounding-for-veterinary-medicine-market-analysis/

Proposed Solutions
To address these challenges, several solutions can be implemented to ensure the safety and growth of the market.
• Enhanced Quality Control: Compounding pharmacies can invest in advanced technology and stricter quality assurance protocols to ensure the potency, purity, and stability of their products. This includes mandatory third-party testing and adherence to established compounding standards.
• Veterinarian-Pharmacist Collaboration: Fostering a stronger partnership between veterinarians and compounding pharmacists can ensure that compounded medications are used only when medically necessary and that veterinarians are fully informed about the compounded product's formulation and administration.
• Consumer Education: Increased awareness campaigns for both pet owners and veterinarians can highlight the importance of using FDA-approved drugs whenever possible and the specific circumstances where a compounded medication is the best or only option.

US Tariff Implications
The US tariff policies have a notable impact on the veterinary compounding market. While finished pharmaceutical products are often exempt, tariffs can be levied on imported medical supplies and, most significantly, on the chemical precursors and APIs used in compounding. These tariffs, which can be as high as 25%, increase the cost of raw materials. This additional cost is often passed down the supply chain to distributors, veterinarians, and ultimately, the pet owner. This can lead to increased costs for treatments and, in some cases, potential drug shortages if foreign manufacturers abandon the production of low-margin generic ingredients.

Download the full report now to discover market trends, opportunities, and strategies for success.
https://evolvebi.com/report/pharmacy-compounding-for-veterinary-medicine-market-analysis/

To understand further and explore opportunities in the Pharmacy Compounding for Veterinary Medicine Market or any related industry please share your queries/concern at info@evolvebi.com.

Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing
innovative solutions to challenging pain points of a business. Our market research reports include data
useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere
data collection to business advisory.

Evolve Business Intelligence is built on account of technology advancement providing highly accurate
data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-
time data including, quarter performance, annual performance, and recent developments from
fortune's global 2000 companies.

This release was published on openPR.